Psychopathology in methamphetamine-dependent adults 3 years after treatment. - Wikidata - wikimedia - TriplyDB

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

http://www.wikidata.org/entity/Q37168175

about

Efficacy of psychostimulant drugs for amphetamine abuse or dependence Efficacy of Psychostimulant Drugs for Amphetamine Abuse or Dependence The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrations Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction Methamphetamine toxicity and its implications during HIV-1 infection.The methamphetamine problem in the United States.Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors.Randomized trial of intensive motivational interviewing for methamphetamine dependence.Interaction of motivation and psychiatric symptoms on substance abuse outcomes in sober living houses.Psychiatric comorbidity in methamphetamine dependence.Exercise for methamphetamine dependence: rationale, design, and methodology.Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment.Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning.Modafinil for the treatment of methamphetamine dependence Predictors of depressive symptomatology among rural stimulant users.Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use.Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study.More alike than different: health needs, services utilization, and outcomes of Asian American and Pacific Islander (AAPI) populations treated for substance use disorders Eight weeks of exercise training improves fitness measures in methamphetamine-dependent individuals in residential treatment.Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes Course of Psychiatric Symptoms and Abstinence among Methamphetamine-Dependent Persons in Sober Living Recovery Homes.Does Posttraumatic Stress Disorder (PTSD) Affect Post-Treatment Methamphetamine Use?Methamphetamine psychosis: epidemiology and management Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorder.Item response theory analyses of DSM-IV and DSM-5 stimulant use disorder criteria in an American Indian community sample.The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.Sigma Receptors and Substance Use Disorders.Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center.Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction.Effects of acute and chronic systemic methamphetamine on respiratory, cardiovascular and metabolic function, and cardiorespiratory reflexes.Mental health correlates of drug treatment among women who use methamphetamine.Individual and Network Correlates of Antisocial Personality Disorder Among Rural Nonmedical Prescription Opioid Users.Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes.Cognitive enhancement in combination with 'brain repair' may be optimal for the treatment of stimulant addiction.Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users.A longitudinal study of self-reported psychopathology in early ecstasy and amphetamine users.

P2860

Q24198261-A30C616E-8596-462A-B7A7-3EA29B897A3A Q24203609-BE503E99-F81B-4103-BE26-F962243425B3 Q28397865-08620D9B-B104-48B9-9149-72B09DC318BC Q28486981-DF04719B-FC68-45F3-AD6B-6B2FBA7B9542 Q33985461-A6C87E1A-09AA-4250-88E3-07899DCF89D9 Q34092520-3EC07039-9664-4F3F-92D0-286A84CAE18D Q34167524-CB39FA75-D430-42B5-AB73-6BC03CB5F331 Q34256300-09D8D251-2EF2-45B6-8C11-2108DB64D3EA Q34404592-2E35D275-FF84-4E6C-9D1C-60D2D084D00C Q34473977-9E97C711-28E7-4103-8F42-0AEBC3780CA0 Q34614735-76BEC619-3CB0-4CBC-AA49-A425D788DBDA Q34682603-49FEB950-403C-4D8F-BD63-D40D75E1B167 Q35056994-074DFC78-BF74-4F78-896B-4D5650FBCF01 Q35174547-322696BF-D730-4FFB-B01C-5714B3715DAF Q35174572-238B6F58-EC9A-4182-849F-4DB337082A4B Q35583271-9B7A0295-C76C-449E-B47B-F28CFAF65ED4 Q35872298-8D2F3E20-5EDB-4D16-B302-D687E5BBE8E2 Q36069092-D4B631B7-6845-4C2C-8413-51229614739F Q36381738-AB52C9D8-BC23-4AC5-8167-D2A5469DB02A Q36479381-696A0B06-7BD7-45F4-A664-4D99B1BE90A8 Q36742679-90EFF5B8-06B9-4FB6-A17D-DAA1C164B190 Q37029535-B33A4BA5-36DB-436B-B31A-B92775A1F408 Q37095626-18CFC8F7-1815-4396-AF93-B83422EF360D Q37188644-B53F07CD-9592-4B65-8718-340CEEBCC406 Q37265315-61495ACB-E0D1-46E5-BECD-3A41DF866C97 Q37316136-FA4F0CD9-B8AE-4014-9365-4E8D38957AF0 Q37561266-7E7BF761-0161-4999-9BEA-FA05AE4215AB Q38825321-C9C4D707-48FA-43F2-A211-A1C0F0732C63 Q39185737-FA6C0107-9FA2-4F65-A386-5CBA0F818404 Q39370565-4F01F627-D8E2-48C0-B969-BC9F4B33E175 Q39563166-46753C13-46D4-48AD-A161-63B074F5806C Q40301697-6EA2FD9B-EEBE-4466-A990-41BE2F759904 Q40307680-8B09CD3E-A8F1-4624-BECB-E2BA4C519EA7 Q40677562-D9A8FC14-5B2C-45DD-8893-9AFF6061D8F9 Q41020780-CF8AB5C3-3FE5-44D4-899E-C7B37CDB4739 Q41703239-42A5F0C4-4E4F-49A6-A8D5-CE57959E1E55 Q42267653-DAF2E035-6FD3-47C6-B18D-3F6832D8D237 Q42574189-BD6DF139-9C8A-4C35-975A-1F4D1916BE72 Q42721564-D525F8BE-5F4E-4CCA-AF65-C27E12C8AE44 Q45099576-D2AF04B0-427A-4D16-A0E9-BE3580E4380F

P2860

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

http://www.wikidata.org/entity/Q37168175

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

@en

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

@nl

type

label

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

@en

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

@nl

prefLabel

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

@en

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

@nl

P1433

Q37168175-E499AEB3-9F73-45D2-B753-9F94FDED213C

P1476

Q37168175-593B5916-F1FF-4B0E-A3CF-0B010494B7AA

P2093

Q37168175-42F7ABCB-E0FF-4296-9C7F-A0C1253FAA15

Q37168175-658CA72A-0763-4418-AF3B-3856825CE08E

Q37168175-7F3B1D3B-8534-4B8D-A827-5C52E948E1EF

Q37168175-B9379C8E-2CE7-49EB-B6AB-21096B966C1C

Q37168175-E3D9AFC7-98EE-480A-96B0-EF198F40607F

P2860

Q37168175-0992A10C-5FDB-486F-90A9-CD45AFC41618

Q37168175-122F4A41-9698-4B77-AFC2-FD6A9CD8FCF3

Q37168175-14E4FDBD-C224-4B4E-8DE9-A6DEA61DC1F7

Q37168175-15E909D3-0F65-4411-99BF-63E728ABBA97

Q37168175-1666AE0E-0A5D-49C2-B2EC-8652C9D70189

Q37168175-26F9CCBA-4E98-4A8E-8F0C-47403AD82B94

Q37168175-335B74F3-32D4-4B03-801B-B262257B6A14

Q37168175-3F85911E-B511-44A9-A4CB-17613C7C9720

Q37168175-53AEB822-9191-4EAB-B99D-D744A3DD35E7

Q37168175-55FAF213-DE30-41FD-88C1-DED1926AC7B9

P304

Q37168175-F0893D98-E846-4036-9C7F-3F4287B78C03

P31

Q37168175-F8D023D4-5BB1-4AB6-B56F-126F59D317F5

P356

Q37168175-FD3B36D6-8A02-46AC-86D8-4C65F569EA83

P433

Q37168175-14FDF2BE-124D-410A-813F-B58C769CE2A4

P478

Q37168175-650B058A-2627-44D9-88E9-E0F05DD0357F

P50

Q37168175-0E01D718-02BD-4CE9-8513-F939BC00FC25

Q37168175-E7F777AA-79F1-44BB-B038-16A7B7609A51

P577

Q37168175-66EF6DEF-AF6B-4DBD-8D7F-934F7CF11886

P698

Q37168175-178C0301-1159-4D93-9614-8E67FB5F0156

P932

Q37168175-199F5CA7-327B-4054-93E3-1FC9015A425B

P356

J.1465-3362.2009.00081.X

P1433

Drug and Alcohol Review

P1476

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

@en

P2093

Alfonso Ang

http://www.w3.org/2001/XMLSchema#string

Larissa J Mooney

http://www.w3.org/2001/XMLSchema#string

Maureen Hillhouse

http://www.w3.org/2001/XMLSchema#string

Patricia Marinelli-Casey

http://www.w3.org/2001/XMLSchema#string

Richard A Rawson

http://www.w3.org/2001/XMLSchema#string

P2860

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

Differences between methamphetamine users and cocaine users in treatment.

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Estimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area Survey.

Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders.

Antisocial personality disorder and TC treatment outcomes.

A 33-year follow-up of narcotics addicts.

Risk factors for symptom exacerbation among treated patients with substance use disorders.

P304

12-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1465-3362.2009.00081.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Suzette Glasner-Edwards

Methamphetamine Treatment Project Corporate Authors

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20078677

http://www.w3.org/2001/XMLSchema#string

P932

3772133

http://www.w3.org/2001/XMLSchema#string